πŸ‡ΊπŸ‡Έ FDA
Patent

US 8557859

Immunomodulatory compositions

granted A61KA61K31/407A61K31/7028

Quick answer

US patent 8557859 (Immunomodulatory compositions) held by Summit (Wales) Limited expires Mon Oct 10 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Summit (Wales) Limited
Grant date
Tue Oct 15 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 10 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K31/407, A61K31/7028, A61K35/15, A61K36/185